Skip to main content

Advertisement

Table 1 Clinicopathological findings of 837 patients with advanced proximal gastric cancer

From: Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study

  N NSR (n = 572) CR (n = 152) SPR (n = 113) P
Gender      0.947
 Male 668 457 (68.4%) 120 (18.0%) 91 (13.6%)  
 Female 169 115 (68.0%) 32 (18.9%) 22(13.0%)  
Age      0.387
  < 60 years 460 306 (66.5%) 86 (18.7%) 68 (14.8%)  
  ≥ 60 years 377 266 (70.6%) 66 (17.5%) 45 (11.9%)  
Tumor size      < 0.001
  < 5 cm 358 264 (73.7%) 38 (10.6%) 56 (15.6%)  
  ≥ 5 cm 479 308(64.3%) 114 (23.8%) 57 (11.9%)  
Gastrectomy type      0.106
 Proximal 335 244 (72.8%) 52 (15.5%) 39 (11.6%)  
 Total 502 328 (65.3%) 100 (19.9%) 74 (14.7%)  
Greater curvature involved     < 0.001
 No 617 445 (72.1%) 91 (14.7%) 81 (13.1%)  
 Yes 220 127 (57.7%) 61 (27.7%) 32 (14.5%)  
pT stage      < 0.001
 pT2 96 75 (78.1%) 8 (8.3%) 13 (13.5%)  
 pT3 282 212 (75.2%) 28 (9.9%) 42 (14.9%)  
 pT4a 459 285 (62.1%) 116 (25.3%) 58 (12.6%)  
pN stage      0.003
 pN0 266 198 (74.4%) 42 (15.8%) 26 (9.8%)  
 pN1 149 106 (71.1%) 31(20.8%) 12 (8.1%)  
 pN2 180 122 (67.8%) 26 (14.4%) 32 (17.8%)  
 pN3a-3b 242 146 (60.3%) 53 (21.9%) 43 (17.8%)  
pTNM stage      < 0.001
 IB-IIA 168 138 (82.1%) 12 (7.1%) 18 (10.7%)  
 IIB-IIIA 432 293 (67.8%) 87 (20.1%) 52 (12.0%)  
 IIIB-IIIC 237 141 (59.5%) 53 (22.4%) 43 (18.1%)  
Bormann type      0.475
 Bor 1–2 160 107 (66.9%) 34 (21.3%) 19 (11.9%)  
 Bor 3–4 677 465 (68.7%) 118 (17.4%) 94 (13.9%)  
  1. NSR: Nosplenic hilar orsplenic arteryLN resection, CR: combination resectionof the stomach and spleen or spleen-co-pancreas, SPR: spleen-preserved No. 10/11 LNs removal